Drug details
Daklinza (daclatasvir tablets)
type of
Daklinza (daclatasvir) is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir for the treatment of chronic HCV genotype 3.
The drug is often used to treat Hepatitis C .
This drug may have the following side effects:
- nausea,
- headache,
- diarrhea,
- insomnia,
- rash,
- fatigue,
- dizziness, and
- low levels of iron in the blood (anemia),
- drowsiness.
The following drugs are related to Daklinza, either as a replacement or used together:
- Moderiba (ribavirin tablets)
- Ocaliva (obeticholic acid tablets)
- Vemlidy Tablets (tenofovir alafenamide)